12 March 2002
Loss of heterozygosity in primary lung cancer using laser capture microdissection and WAVE DNA fragment analysis techniques.
Helen Zou, Amy Beck, Dave Chervinsky, Weigang Zhu, Debbie Malik, John Brooks, Dongfeng TanMed Sci Monit 2002; 8(3): BR95-99 :: ID: 420892
Abstract
BACKGROUND:A number of molecular changes observed by varied conventionalmethods, including loss of heterozygosity (LOH) on chromosome 3, have been associated with primary lungcancer. To further define the locus of chromosome 3p allele loss in lung cancer, we performed LOH studyby using innovative laser capture microdissection and WAVE DNA Fragment Analysis. MATERIAL/METHODS: Thirty-eightpaired specimens from patients with adenocarcinoma of the lung were used for this study. Formalin-fixed,paraffin-embedded tissue from normal stromal cells or lymphocytes and adenocarcinoma were collected usinglaser capture microdissection. DNA was extracted and amplified by PCR using six polymorphic DNA markersfor chromosome 3. PCR products were analyzed by both gel electrophoresis and WAVE DNA Fragment Analysis.RESULTS: LOH at 3p22-24 was found in tumor cells from twelve out of thirty-eight patients (32%) whenanalyzed by WAVE DNA Fragment Analysis and LOH was found in tumor cells from nine out of thirty-eightpatients (23%) when analyzed by gel electrophoresis. LOH was found in normal control from one out ofthirty-eight patients. CONCLUSIONS: 1. Our results suggest putative tumor suppressor gene(s) is presentin a region at 3p22-24, which may play a role in carcinogenesis of lung cancer. 2. Laser capture microdissectionis essential tool for defined LOH studies. 3. WAVE DNA Fragment Analysis is an accurate, sensitive andautomated tool for analysis of DNA fragments.
Keywords: Aged, 80 and over, Alleles, Chromosomes, Human, Pair 3, DNA Fragmentation, Lasers, Loss of Heterozygosity, Polymerase Chain Reaction, Polymorphism, Genetic, Research Support, Non-U.S. Gov
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952